Translational Control of Retroviral Unspliced mRNA
逆转录病毒未剪接 mRNA 的翻译控制
基本信息
- 批准号:7039375
- 负责人:
- 金额:$ 20.35万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2006
- 资助国家:美国
- 起止时间:2006-02-03 至 2011-01-31
- 项目状态:已结题
- 来源:
- 关键词:DNA binding proteinRNA interferenceRetroviridaebiological modelsgene expressiongenetic enhancer elementgenetic translationhelicasemass spectrometryposttranscriptional RNA processingposttranslational modificationsprotein protein interactionprotein structureprotein structure functionsite directed mutagenesistranslation factor
项目摘要
DESCRIPTION (provided by applicant): Retroviruses vary widely in their ability to cause neoplastic transformation or immunodeficiency. In addition, retroviruses are used as a backbone for constructing nonpathogenic vectors for gene transfer applications. However, in all cases, retroviruses recruit host cell proteins to achieve cytoplasmic expression of their unspliced genome-length RNA. We have identified sequences adjacent to the 5' cap of spleen necrosis virus (SNV) that facilitate Rev/Rev responsive element (RRE)-independent expression of HIV-1 unspliced reporter RNA. The RU5 region of the SNV long terminal repeat functions as a distinct position- and orientation-dependent cap-dependent translational enhancer of intron-containing HIV-1 gag RNA as well as nonviral luciferase (luc) RNA. Designated the SNV post-transcriptional control element (PCE). polysome analyses indicate that its functional mechanism is to stimulate translation initiation, although the PCE is not an internal ribosome entry sequence. Recently, we identified PCE activity in the 5' RNA terminus of two divergent retroviruses and in a cellular protooncogene mRNA. Our novel hypothesis is that 5' PCEs are a feature shared among divergent retroviruses and selected cellular mRNAs to achieve efficient translation in the face of multiple barriers to efficient cytoplasmic expression. Combined results of site-directed mutagenesis, RNA affinity chromatography and MALDI-TOF mass spectroscopy have determined redundant stem-loop motifs are necessary for PCE activity and that the structural features of the PCE present unpaired nucleotides for interaction with RNA helicase A (RHA). Knockdown of endogenous RHA by RNA silencing eliminates PCE translation stimulation and demonstrates that RHA is necessary for PCE activity. Our findings have generated the following essential questions: i) What conserved motifs necessary for translation stimulation are shared among retroviral PCEs? ii) What residues in RHA are necessary for interaction with the PCE and with translation factors or auxiliary proteins that mediate PCE activity? iii) What step of translation is stimulated? The overall goal of this proposal is to characterize the biochemical mechanism of PCE-RHA translational enhancement. Three integrated Specific Aims for this proposal are: 1) to define conserved features in PCEs among divergent retroviruses; 2) to define the domains of RNA helicase A necessary for PCE translational enhancement; and 3) to evaluate the function of the PCE-RHA interaction in translation initiation. Our results will illuminate a unique control mechanism of eukaryotic post-transcriptional gene expression and define virus-host interactions that are important for viral replication and progression to disease. Our new fundamental knowledge of translational control will define the process by which cellular mRNAs become committed to cytoplasmic expression and produce new strategies to optimize vector systems for diverse gene transfer applications.
描述(由申请方提供):逆转录病毒在引起肿瘤转化或免疫缺陷方面的能力差异很大。此外,逆转录病毒被用作构建用于基因转移应用的非致病性载体的骨架。然而,在所有情况下,逆转录病毒募集宿主细胞蛋白质以实现其未剪接的基因组长度RNA的细胞质表达。我们已经鉴定了脾坏死病毒(SNV)5'帽附近的序列,这些序列有助于HIV-1未剪接报告RNA的Rev/Rev反应元件(RRE)非依赖性表达。SNV长末端重复序列的RU 5区域作为含内含子的HIV-1 gag RNA以及非病毒荧光素酶(luc)RNA的独特位置和方向依赖性帽依赖性翻译增强子发挥功能。命名为SNV转录后控制元件(PCE)。多核糖体分析表明,其功能机制是刺激翻译起始,虽然PCE不是内部核糖体进入序列。最近,我们在两种不同的逆转录病毒的5' RNA末端和细胞原癌基因mRNA中鉴定了PCE活性。我们的新假设是5'PCE是不同逆转录病毒和选择的细胞mRNA之间共享的特征,以在面对有效细胞质表达的多重障碍时实现有效翻译。定点诱变、RNA亲和层析和MALDI-TOF质谱的组合结果已经确定了冗余的茎环基序对于PCE活性是必需的,并且PCE的结构特征呈现与RNA解旋酶A(RHA)相互作用的未配对核苷酸。通过RNA沉默敲低内源性RHA消除了PCE翻译刺激,并证明RHA是PCE活性所必需的。我们的研究结果产生了以下基本问题:i)逆转录病毒PCE之间共享哪些翻译刺激所需的保守基序?ii)RHA中的哪些残基是与PCE以及介导PCE活性的翻译因子或辅助蛋白相互作用所必需的?(3)翻译的哪一步是被激发的?该提案的总体目标是表征PCE-RHA翻译增强的生化机制。该提案的三个综合具体目标是:1)确定不同逆转录病毒中PCE的保守特征; 2)确定PCE翻译增强所需的RNA解旋酶A结构域; 3)评价PCE-RHA相互作用在翻译起始中的功能。我们的研究结果将阐明真核转录后基因表达的独特控制机制,并定义病毒-宿主相互作用,这对病毒复制和疾病进展至关重要。我们对翻译控制的新的基础知识将定义细胞mRNA致力于细胞质表达的过程,并产生新的策略来优化载体系统以用于不同的基因转移应用。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Kathleen A. Boris-Lawrie其他文献
Kathleen A. Boris-Lawrie的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Kathleen A. Boris-Lawrie', 18)}}的其他基金
Characterization of RHA:RT interactions in HIV-1 reverse transcription
HIV-1 逆转录中 RHA:RT 相互作用的表征
- 批准号:
10403061 - 财政年份:2022
- 资助金额:
$ 20.35万 - 项目类别:
Characterization of RHA:RT interactions in HIV-1 reverse transcription
HIV-1 逆转录中 RHA:RT 相互作用的表征
- 批准号:
10614580 - 财政年份:2022
- 资助金额:
$ 20.35万 - 项目类别:
Translational Control of Retroviral Unspliced mRNA
逆转录病毒未剪接 mRNA 的翻译控制
- 批准号:
7339629 - 财政年份:2006
- 资助金额:
$ 20.35万 - 项目类别:
Translational Control of Retroviral Unspliced mRNA
逆转录病毒未剪接 mRNA 的翻译控制
- 批准号:
7544521 - 财政年份:2006
- 资助金额:
$ 20.35万 - 项目类别:
Translational Control of Retroviral Unspliced mRNA
逆转录病毒未剪接 mRNA 的翻译控制
- 批准号:
7996196 - 财政年份:2006
- 资助金额:
$ 20.35万 - 项目类别:
Translational Control of Retroviral Unspliced mRNA
逆转录病毒未剪接 mRNA 的翻译控制
- 批准号:
7176238 - 财政年份:2006
- 资助金额:
$ 20.35万 - 项目类别:
Retrovirus Models of Cellular Post-transcriptional Gene Expression
细胞转录后基因表达的逆转录病毒模型
- 批准号:
8376222 - 财政年份:2003
- 资助金额:
$ 20.35万 - 项目类别:
Retrovirus Models of Cellular Post-transcriptional Gene Expression
细胞转录后基因表达的逆转录病毒模型
- 批准号:
8079529 - 财政年份:2003
- 资助金额:
$ 20.35万 - 项目类别:
相似海外基金
Investigation of improvement of skeletal muscle function by RNA interference for prevention of frailty
通过 RNA 干扰改善骨骼肌功能预防衰弱的研究
- 批准号:
23K10830 - 财政年份:2023
- 资助金额:
$ 20.35万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Tissue Adhesive RNA Interference Nanoparticles to Block Progression of Posttraumatic and Spontaneous Osteoarthritis.
组织粘附 RNA 干扰纳米颗粒可阻止创伤后和自发性骨关节炎的进展。
- 批准号:
10539405 - 财政年份:2022
- 资助金额:
$ 20.35万 - 项目类别:
Tissue Adhesive RNA Interference Nanoparticles to Block Progression of Posttraumatic and Spontaneous Osteoarthritis.
组织粘附 RNA 干扰纳米颗粒可阻止创伤后和自发性骨关节炎的进展。
- 批准号:
10688080 - 财政年份:2022
- 资助金额:
$ 20.35万 - 项目类别:
Using RNA interference to combat the worst emerging disease of wildlife
利用 RNA 干扰对抗野生动物最严重的新疾病
- 批准号:
DP220101361 - 财政年份:2022
- 资助金额:
$ 20.35万 - 项目类别:
Discovery Projects
RNA Interference and Heterochromatic Silencing in Replication and Quiescence
复制和静止过程中的 RNA 干扰和异染色质沉默
- 批准号:
10677770 - 财政年份:2022
- 资助金额:
$ 20.35万 - 项目类别:
Regulation of RNA interference pathways by extracellular cues
细胞外信号对 RNA 干扰途径的调节
- 批准号:
RGPIN-2019-04411 - 财政年份:2022
- 资助金额:
$ 20.35万 - 项目类别:
Discovery Grants Program - Individual
CAREER: Investigating the Role of an RNA Interference Pathway in Safeguarding the Tetrahymena Thermophila Somatic Genome
职业:研究 RNA 干扰途径在保护嗜热四膜虫体细胞基因组中的作用
- 批准号:
2143019 - 财政年份:2022
- 资助金额:
$ 20.35万 - 项目类别:
Continuing Grant
New Cancer Therapy: A Combination of RNA Interference and Gene Therapy
新的癌症疗法:RNA干扰和基因疗法的结合
- 批准号:
486535 - 财政年份:2022
- 资助金额:
$ 20.35万 - 项目类别:
Studentship Programs
RNA Interference and Heterochromatic Silencing in Replication and Quiescence
复制和静止过程中的 RNA 干扰和异染色质沉默
- 批准号:
10330828 - 财政年份:2022
- 资助金额:
$ 20.35万 - 项目类别:
CAREER: Abiotic degradation of emerging RNA interference pesticides
职业:新兴 RNA 干扰农药的非生物降解
- 批准号:
2046602 - 财政年份:2021
- 资助金额:
$ 20.35万 - 项目类别:
Continuing Grant